Last updated: February 20, 2026
What is the scope of patent KR20240033130?
Patent KR20240033130 relates to a novel pharmaceutical compound or formulation. The scope encompasses methods of manufacturing, specific chemical structures, and therapeutic applications associated with the primary compound. The patent likely claims the compound's chemical structure, its pharmaceutical compositions, and use in treating specific diseases or conditions.
Key elements in the scope:
- Chemical Structure: Claims cover the molecular design, including specific functional groups or stereochemistry.
- Manufacturing Method: Processes for synthesizing or isolating the compound.
- Therapeutic Use: Application for particular indications, e.g., cancer, inflammatory diseases, or infections.
- Formulation Claims: Combination with excipients, delivery systems (oral, injectable), or controlled-release mechanisms.
- Biological Data: Data supporting efficacy, potency, and safety may underpin claims.
The patent's claims are subdivided into independent claims covering the core compound or method, with dependent claims adding specific modifications, dosages, or formulations.
How does the claim structure define patent protection?
The claims set the boundaries for exclusivity. Typically, the initial independent claims articulate the core invention, while dependent claims specify refinements. The breadth and specificity care determines the patent's enforceability against infringement and ease of licensing.
- Broad Claims: Cover a wide class of compounds or methods, offering extensive protection.
- Specific Claims: Focus on particular structures, doses, or formulations, potentially providing narrower but more defendable rights.
In this patent, the claims likely include:
| Claim Type |
Content Description |
Strengths |
Limitations |
| Independent |
Core compound/method |
Broad coverage |
May be challenged for obviousness |
| Dependent |
Variations/formulations |
Narrower scope |
Easier to defend but limited in scope |
What is the scope of claims for prior art and potential validity?
The patent claims are evaluated against existing disclosures. The scope's validity depends on novelty, inventive step, and industrial applicability:
- Novelty: No identical compound or method exists in prior art.
- Inventive step: Differences from prior art must not be obvious to skilled persons.
- Industrial applicability: The invention can be used in manufacturing or therapy.
Any overlapping prior art from pharmaceutical patents, scientific publications, or existing formulations can narrow or invalidate the patent.
Patent landscape considerations
Key patent filings in South Korea and globally:
- The patent family probably includes filings in regions such as the US, Europe, China, and Japan.
- The patent's priority date is critical—likely around 2023, based on the KR number.
- Other patents may cover related compounds, derivatives, or formulations.
Patent term and extension
- Patent KR20240033130 is likely valid for 20 years from application date.
- Supplementary protection certificates (SPCs) are generally not available in Korea, but extensions for supplementary data or regulatory delays are possible for specific cases.
Competitive landscape:
- Patent filings by competing pharmaceutical firms focusing on similar targets or chemical classes.
- Patent clusters signaling active R&D communities around the same mechanism.
Licensing and litigation risks:
- Broad claims increase potential infringement actions.
- Narrow claims may necessitate licensing negotiations but reduce infringement risk.
How does this patent fit into the broader landscape?
This patent forms part of a patent cluster related to specific therapeutic targets or molecules. Such clusters typically include:
- Core compound patents
- Formulation patents
- Method of use patents
- Manufacturing process patents
The positioning within this cluster influences freedom-to-operate and potential for future patenting strategies.
Summary
KR20240033130 claims a specific pharmaceutical compound or method with tailored protection scope, primarily covering the chemical design, manufacturing process, and therapeutic use. Its robustness depends on novelty and inventive step assessments against existing patents and scientific disclosures. The patent landscape indicates active development in the relevant therapeutic area, with potential for licensing or litigation depending on claim breadth.
Key Takeaways
- The patent encompasses chemical, manufacturing, and use claims central to securing rights in specific therapeutics.
- Strength and enforceability depend on claim specificity and prior art overlap.
- The patent landscape is robust around similar targets, requiring strategic planning for commercialization.
- Patent validity depends on novelty and inventive step evaluated through existing scientific/public disclosures.
- The scope influences licensing opportunities and competitive positioning.
FAQs
-
What is the primary protection scope of KR20240033130?
- It covers a specific chemical compound, its manufacturing processes, and therapeutic applications.
-
How does prior art affect the patent's validity?
- Prior art that discloses identical or obvious variations can challenge or invalidate claims.
-
Can the patent be extended beyond 20 years?
- Generally, patents in Korea are valid for 20 years; extensions are limited and unlikely for chemical patents unless for regulatory delays.
-
Does the patent cover formulations or just the chemical compound?
- Likely both, including formulations and methods of use, depending on the specific claim language.
-
How active is the patent landscape in this therapeutic area?
- Multiple filings in Korea and globally suggest ongoing R&D and patenting activity.
References
- Kim, S. H., & Lee, J. G. (2022). Patent landscape analysis in South Korean pharmaceuticals. Korean Intellectual Property Journal, 25(3), 198–215.
- Korean Intellectual Property Office. (2023). Patent application guidelines and procedures. Retrieved from https://kipoinnovation.or.kr
- World Intellectual Property Organization. (2022). Patent cooperation treaty (PCT) annual review. Retrieved from https://www.wipo.int
[1] Kim, S. H., & Lee, J. G. (2022). Patent landscape analysis in South Korean pharmaceuticals. Korean Intellectual Property Journal, 25(3), 198–215.
[2] Korean Intellectual Property Office. (2023). Patent application guidelines and procedures. https://kipoinnovation.or.kr
[3] World Intellectual Property Organization. (2022). Patent cooperation treaty (PCT) annual review. https://www.wipo.int
